EGFR Dinucleotide Repeat Polymorphism as a Prognostic Indicator in Non-small Cell Lung Cancer
- 1 June 2006
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 1 (5) , 406-412
- https://doi.org/10.1097/01243894-200606000-00005
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With ErlotinibJournal of Clinical Oncology, 2005
- An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor InhibitorsCancer Research, 2004
- Modification of Breast Cancer Risk in Young Women by a Polymorphic Sequence in the egfr GeneCancer Research, 2004
- Epidermal Growth Factor Receptor in Non–Small-Cell Lung Carcinomas: Correlation Between Gene Copy Number and Protein Expression and Impact on PrognosisJournal of Clinical Oncology, 2003
- Epidermal growth factor receptor family in lung cancer and premalignancySeminars in Oncology, 2002
- Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant TherapyJournal of Clinical Oncology, 2001
- A strong intronic enhancer element of the EGFR gene is preferentially active in high EGFR expressing breast cancer cellsJournal of Cellular Biochemistry, 2000
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1Journal of Biological Chemistry, 1999